| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.687 | 12.114 | 9.815 | 11.180 | 15.248 | 9.070 | 12.869 | 14.703 | 10.659 | 7.740 |
| Total Income - EUR | 11.687 | 12.114 | 9.815 | 11.180 | 15.248 | 13.764 | 12.869 | 14.703 | 10.659 | 7.740 |
| Total Expenses - EUR | 24.409 | 22.359 | 14.030 | 4.929 | 4.330 | 6.194 | 7.027 | 5.134 | 8.146 | 11.561 |
| Gross Profit/Loss - EUR | -12.722 | -10.245 | -4.215 | 6.251 | 10.917 | 7.570 | 5.843 | 9.569 | 2.514 | -3.821 |
| Net Profit/Loss - EUR | -13.073 | -10.366 | -4.354 | 5.916 | 10.460 | 7.319 | 5.456 | 9.128 | 1.847 | -3.821 |
| Employees | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Policlinica Royaldent S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.563 | 7.817 | 6.350 | 5.331 | 4.495 | 148.215 | 145.721 | 143.010 | 139.370 | 134.827 |
| Current Assets | 7.839 | 4.840 | 3.231 | 27.346 | 28.282 | 8.679 | 5.509 | 6.338 | 3.851 | 11.590 |
| Inventories | 0 | 0 | 0 | 24.565 | 24.089 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.263 | 3.851 | 2.309 | 1.056 | 1.332 | 2.341 | 3.023 | 2.422 | 2.179 | 1.785 |
| Cash | 2.577 | 988 | 922 | 1.724 | 2.861 | 6.338 | 2.486 | 3.917 | 1.673 | 9.805 |
| Shareholders Funds | -168.833 | -177.477 | -178.828 | -169.631 | -155.886 | -145.612 | -136.926 | -127.907 | -125.672 | -128.791 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 186.236 | 190.134 | 188.409 | 202.308 | 188.664 | 302.506 | 288.157 | 277.255 | 268.894 | 275.208 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Policlinica Royaldent S.r.l.